Insider · CIK 0001727789
Mitchell Shirvan
Files at SLXN (Silexion Therapeutics Corp). First filing Mar 30, 2026, latest Mar 30, 2026.
In brief
Mitchell Shirvan files SEC Form 4 as officer at SLXN (Silexion Therapeutics Corp). Since Mar 30, 2026, Mitchell Shirvan has reported 0 open-market buys worth $0 and 1 open-market sell worth $31k, the latest filed on Mar 30, 2026.
A track record needs three past buys with six months of prices behind them; Mitchell Shirvan has 0, so none is measured yet.
The newest scored trade: sold $31k of SLXN on Mar 26, 2026, filed Mar 30, 2026, scored 30 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $31k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SLXN: Silexion Therapeutics Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | SLXNsell Silexion Therapeutics Corp | $31k 22,818 shares | -45% | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | SLXN Silexion Therapeutics Corp | AGrant or award Ordinary Shares | +6,000 | $0.00 | $0 | 8,789 | Jun 8, 2026 |
| Mar 26, 2026 | SLXN Silexion Therapeutics Corp | SOpen-market sale Ordinary Shares | -22,818 | $1.36 | $31k | 27,889 | Mar 30, 2026 |
| Feb 20, 2026 | SLXN Silexion Therapeutics Corp | AGrant or award Ordinary Shares | +49,726 | $0.00 | $0 | 50,707 | Feb 23, 2026 |
Questions about Mitchell Shirvan
Answered from the filings on this page, as of the latest one.
Is Mitchell Shirvan buying or selling?
In the last 12 months Mitchell Shirvan reported 0 open-market buys worth $0 and 1 open-market sell worth $31k on SEC Form 4; the latest was sold $31k of SLXN on Mar 26, 2026. Grants, option exercises and tax withholding are not counted.
How did Mitchell Shirvan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mitchell Shirvan has 0.
Where does Mitchell Shirvan file Form 4?
Mitchell Shirvan has filed Form 4 at SLXN (Silexion Therapeutics Corp) as CSO and CDO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.